device and drug medical limited Company Information
Company Number
11772879
Next Accounts
Oct 2025
Industry
Other business support service activities n.e.c.
Shareholders
salah-din sliman
Group Structure
View All
Contact
Registered Address
suite 7 savant house, 63-65 camden high street, london, NW1 7JL
Website
www.dndmed.comdevice and drug medical limited Estimated Valuation
Pomanda estimates the enterprise value of DEVICE AND DRUG MEDICAL LIMITED at £0 based on a Turnover of £0 and 0.53x industry multiple (adjusted for size and gross margin).
device and drug medical limited Estimated Valuation
Pomanda estimates the enterprise value of DEVICE AND DRUG MEDICAL LIMITED at £0 based on an EBITDA of £-5 and a 3.89x industry multiple (adjusted for size and gross margin).
device and drug medical limited Estimated Valuation
Pomanda estimates the enterprise value of DEVICE AND DRUG MEDICAL LIMITED at £234 based on Net Assets of £100 and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Device And Drug Medical Limited Overview
Device And Drug Medical Limited is a live company located in london, NW1 7JL with a Companies House number of 11772879. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in January 2019, it's largest shareholder is salah-din sliman with a 100% stake. Device And Drug Medical Limited is a young, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Device And Drug Medical Limited Health Check
There is insufficient data available to calculate a health check for Device And Drug Medical Limited. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Device And Drug Medical Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Device And Drug Medical Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Device And Drug Medical Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Device And Drug Medical Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Device And Drug Medical Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Device And Drug Medical Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Device And Drug Medical Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Device And Drug Medical Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Device And Drug Medical Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Device And Drug Medical Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Device And Drug Medical Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Device And Drug Medical Limited
- - Industry AVG
DEVICE AND DRUG MEDICAL LIMITED financials
Device And Drug Medical Limited's latest turnover from January 2024 is estimated at 0 and the company has net assets of £100. According to their latest financial statements, we estimate that Device And Drug Medical Limited has no employees and maintains cash reserves of £100 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | |
---|---|---|---|---|---|
Turnover | |||||
Other Income Or Grants | |||||
Cost Of Sales | |||||
Gross Profit | |||||
Admin Expenses | |||||
Operating Profit | |||||
Interest Payable | |||||
Interest Receivable | |||||
Pre-Tax Profit | |||||
Tax | |||||
Profit After Tax | |||||
Dividends Paid | |||||
Retained Profit | |||||
Employee Costs | |||||
Number Of Employees | |||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | |
---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 0 | 0 | 0 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 0 | 0 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 |
Cash | 100 | 100 | 100 | 100 | 100 |
misc current assets | 0 | 0 | 0 | 0 | 0 |
total current assets | 100 | 100 | 100 | 100 | 100 |
total assets | 100 | 100 | 100 | 100 | 100 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 0 | 0 | 0 | 0 | 0 |
loans | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 |
total liabilities | 0 | 0 | 0 | 0 | 0 |
net assets | 100 | 100 | 100 | 100 | 100 |
total shareholders funds | 100 | 100 | 100 | 100 | 100 |
Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | |
---|---|---|---|---|---|
Operating Activities | |||||
Operating Profit | |||||
Depreciation | 0 | 0 | 0 | 0 | 0 |
Amortisation | 0 | 0 | 0 | 0 | 0 |
Tax | |||||
Stock | 0 | 0 | 0 | 0 | 0 |
Debtors | 0 | 0 | 0 | 0 | 0 |
Creditors | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||
Investing Activities | |||||
capital expenditure | |||||
Change in Investments | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||
Financing Activities | |||||
Bank loans | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 |
share issue | |||||
interest | |||||
cash flow from financing | |||||
cash and cash equivalents | |||||
cash | 0 | 0 | 0 | 0 | 100 |
overdraft | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 0 | 100 |
device and drug medical limited Credit Report and Business Information
Device And Drug Medical Limited Competitor Analysis
Perform a competitor analysis for device and drug medical limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other young companies, companies in NW1 area or any other competitors across 12 key performance metrics.
device and drug medical limited Ownership
DEVICE AND DRUG MEDICAL LIMITED group structure
Device And Drug Medical Limited has no subsidiary companies.
Ultimate parent company
DEVICE AND DRUG MEDICAL LIMITED
11772879
device and drug medical limited directors
Device And Drug Medical Limited currently has 2 directors. The longest serving directors include Mr Salah-Din Sliman (Jun 2020) and Mr Salah-Din Sliman (Jun 2020).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Salah-Din Sliman | United Kingdom | 34 years | Jun 2020 | - | Director |
Mr Salah-Din Sliman | 34 years | Jun 2020 | - | Director |
P&L
January 2024turnover
0
0%
operating profit
-5.3
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2024net assets
100
0%
total assets
100
0%
cash
100
0%
net assets
Total assets minus all liabilities
device and drug medical limited company details
company number
11772879
Type
Private limited with Share Capital
industry
82990 - Other business support service activities n.e.c.
incorporation date
January 2019
age
5
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
January 2024
previous names
N/A
accountant
-
auditor
-
address
suite 7 savant house, 63-65 camden high street, london, NW1 7JL
Bank
-
Legal Advisor
-
device and drug medical limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to device and drug medical limited.
device and drug medical limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DEVICE AND DRUG MEDICAL LIMITED. This can take several minutes, an email will notify you when this has completed.
device and drug medical limited Companies House Filings - See Documents
date | description | view/download |
---|